Skip to main content

Table 1 Characteristics according to age group

From: Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy

 

Age group

Total

 

<5

5–12

13–59

≥60

NK

 
 

n = 610

(21.6%)

n = 317

(11.2%)

n = 1,716

(60.6%)

n = 157

(5.5%)

n = 31

(1.1%)

N = 2,831

 

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

Gender

Male

315 (51.6)

151 (47.6)

606 (35.3)

48 (30.6)

16 (51.6)

1,136 (40.1)

Female

295 (48.4)

166 (52.4)

1,110 (64.7)

109 (69.4)

15 (48.4)

1,695 (59.9)

Facility type

Community pharmacy

4 (0.7)

1 (0.3)

18 (1.1)

3 (1.9)

0 (0)

26 (0.9)

Government

599 (98.2)

312 (98.4)

1,621 (94.5)

153 (97.5)

31 (100)

2,716 (95.9)

Private clinic

4 (0.7)

1 (0.3)

27 (1.6)

0 (0)

0 (0)

32 (1.1)

Quasi-government

3 (0.5)

3 (1.0)

50 (2.9)

1 (0.6)

0 (0)

57 (2.0)

Mode of diagnosis

Doctor

501 (82.1)

242 (76.4)

1,383 (80.6)

125 (79.6)

18 (58.1)

2,269 (80.2)

Laboratory Confirmation

20 (3.3)

19 (6.0)

48 (2.8)

3 (1.9)

1 (3.2)

91 (3.2)

Other health professional

18 (3.0)

22 (6.9)

127 (7.4)

8 (5.1)

5 (16.1)

180 (6.4)

Pharmacist

0 (0)

0 (0)

10 (0.6)

1 (0.6)

0 (0)

11 (0.4)

Self

0 (0)

2 (0.6)

6 (0.4)

0 (0)

0(0)

8 (0.3)

Unknown

71 (11.6)

32 (10.1)

142 (8.3)

20 (12.7)

7 (22.6)

272 (9.6)

Anti-malarial treatment prescribed

Combination therapy

(ART-AQ)

161 (26.4)

181 (57.1)

790 (46.0)

76 (48.4)

9 (29.0)

1,217 (43.0)

Combination therapy

(Other ACT)

240 (39.3)

40 (12.6)

124 (7.2)

5 (3.2)

9 (29.0)

418 (14.8)

Monotherapy

(Artemisinin based)

111 (18.2)

55 (17.4)

700 (40.8)

61 (38.9)

9 (29.0)

936 (33.1)

Monotherapy

(Non-artemisinin)

98 (16.1)

41 (12.9)

102 (5.9)

15 (9.6)

4 (12.9)

260 (9.2)

  1. NK = not known